| Alternative Surgical Policy for Central Liver Tumors (NCT00600522) | University of Milan | 2004-01-01 |
| TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC) (NCT00683631) | University of Louisville | 2004-01-01 |
| FLNA in HCC Patients (NCT03081637) | University of Milan | 2004-01-01 |
| Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer (NCT07386639) | Tongji University | 2004-01-01 |
| Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma (NCT00076609) | PhytoCeutica | 2003-10-01 |
| Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma (NCT00073736) | Ligand Pharmaceuticals | 2003-09-01 |
| Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma (NCT00784290) | Taiho Pharmaceutical Co., Ltd. | 2003-09-01 |
| Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer (NCT00151671) | Rennes University Hospital | 2003-04-01 |
| T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients (NCT00057382) | Tularik | 2003-03-01 |
| Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma. (NCT00043433) | Tularik | 2002-07-01 |
| HAI Via Interventionally Implanted Port Catheter Systems (NCT00356161) | Charite University, Berlin, Germany | 2002-04-01 |
| A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC) (NCT00154817) | National Taiwan University Hospital | 2002-01-01 |
| Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma (NCT00652587) | Sun Yat-sen University | 2002-01-01 |
| Resection for Multiple Hepatocellular Carcinomas (HCC) (NCT01387061) | University of Milan | 2001-06-01 |
| Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads (NCT00054951) | FeRx | 2001-06-01 |
| The Second Multicenter Hemophilia Cohort Study (NCT00341705) | National Cancer Institute (NCI) | 2001-04-27 |
| Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis (NCT01438437) | All India Institute of Medical Sciences | 2001-03-01 |
| Prevention of Recurrent Hepatitis B After Liver Transplantation (NCT00059267) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2001-03-01 |
| Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm (NCT00479050) | Shandong University | 2001-01-01 |
| Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study (NCT00629421) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2001-01-01 |
| Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma (NCT00300521) | Beijing Chao Yang Hospital | 2000-09-01 |
| Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less (NCT05193253) | University Health Network, Toronto | 2000-02-01 |
| Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC (NCT00234182) | The University of Hong Kong | 2000-01-01 |
| Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma (NCT02025842) | Azienda Ospedaliera San Camillo Forlanini | 2000-01-01 |
| Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (NCT01033578) | Fudan University | 1999-10-01 |
| Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis (NCT00273247) | National Cancer Institute, Milan | 1998-06-01 |
| Proton Beam Therapy for Treatment of Hepatocellular Carcinoma (NCT00614913) | Loma Linda University | 1998-05-01 |
| Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma (NCT00149565) | National Health Research Institutes, Taiwan | 1997-10-01 |
| Estimation of Functional Liver Reserve Using Cholinesterases (NCT00883454) | University of Milan | |
| A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma (NCT00319683) | Adherex Technologies, Inc. | |
| Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma (NCT02082691) | Devalingam Mahalingam | |
| HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC (NCT02436044) | Ming Zhao | |
| Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH (NCT02587884) | Eastern Hepatobiliary Surgery Hospital | |
| Therasphere for Unresectable Primary or Secondary Liver Neoplasia (NCT02960620) | H. Lee Moffitt Cancer Center and Research Institute | |
| Replicor Compassionate Access Program (NCT05683548) | Replicor Inc. | |
| Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency (NCT01322477) | Hadassah Medical Organization | |
| Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies (NCT04566393) | xCures | |
| Transient Elastography in Hepatectomy for Hepatocellular Carcinoma (NCT01441453) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies (NCT00057395) | Aronex Pharmaceuticals | |
| TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma (NCT00906984) | University of California, Irvine | |